198 related articles for article (PubMed ID: 15633153)
1. Azathioprine and 6 Mercaptopurine in postoperative maintenance of Crohn's disease remission: is no evidence of effect an evidence of no effect?
Mardini HE
Gastroenterology; 2005 Jan; 128(1):246-8; author reply 248-9. PubMed ID: 15633153
[No Abstract] [Full Text] [Related]
2. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
Prefontaine E; Sutherland LR; Macdonald JK; Cepoiu M
Cochrane Database Syst Rev; 2009 Jan; (1):CD000067. PubMed ID: 19160175
[TBL] [Abstract][Full Text] [Related]
3. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Prefontaine E; Macdonald JK; Sutherland LR
Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
[TBL] [Abstract][Full Text] [Related]
4. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Prefontaine E; Macdonald JK; Sutherland LR
Cochrane Database Syst Rev; 2010 Jun; (6):CD000545. PubMed ID: 20556747
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
7. Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
Mottet C; Schoepfer AM; Juillerat P; Cosnes J; Froehlich F; Kessler-Brondolo V; Seibold F; Rogler G; Vavricka SR; Michetti P
Inflamm Bowel Dis; 2016 Nov; 22(11):2733-2747. PubMed ID: 27760078
[TBL] [Abstract][Full Text] [Related]
8. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.
Hyams JS
Inflamm Bowel Dis; 2005 Feb; 11(2):197-9. PubMed ID: 15677914
[No Abstract] [Full Text] [Related]
9. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance.
Jacobstein DA; Baldassano RN
Inflamm Bowel Dis; 2005 Feb; 11(2):203-5. PubMed ID: 15677916
[No Abstract] [Full Text] [Related]
10. Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine.
Lecomte T; Contou JF; Beaugerie L; Carbonnel F; Cattan S; Gendre JP; Cosnes J
Dis Colon Rectum; 2003 Nov; 46(11):1469-75. PubMed ID: 14605564
[TBL] [Abstract][Full Text] [Related]
11. Use of 6-mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: con.
Griffiths AM
Inflamm Bowel Dis; 2005 Feb; 11(2):200-2. PubMed ID: 15677915
[No Abstract] [Full Text] [Related]
12. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.
Dubinsky MC
Clin Gastroenterol Hepatol; 2004 Sep; 2(9):731-43. PubMed ID: 15354273
[TBL] [Abstract][Full Text] [Related]
13. 6-Mercaptopurine in maintaining remission in Crohn's disease: An old friend becomes a new hero.
Seidman EG
Gastroenterology; 2000 Oct; 119(4):1158-60. PubMed ID: 11040202
[No Abstract] [Full Text] [Related]
14. The debated role for thiopurines in Crohn's disease.
Herrlinger KR; Stange EF
J Crohns Colitis; 2014 Feb; 8(2):172-4. PubMed ID: 24342765
[TBL] [Abstract][Full Text] [Related]
15. 6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease.
Korelitz BI; Present DH
J Crohns Colitis; 2014 Aug; 8(8):735-8. PubMed ID: 24462321
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease.
Sandborn W; Sutherland L; Pearson D; May G; Modigliani R; Prantera C
Cochrane Database Syst Rev; 2000; (2):CD000545. PubMed ID: 10796557
[TBL] [Abstract][Full Text] [Related]
17. Azathioprine for maintaining remission of Crohn's disease.
Pearson DC; May GR; Fick G; Sutherland LR
Cochrane Database Syst Rev; 2000; (2):CD000067. PubMed ID: 10796482
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
Markowitz JF
Rev Gastroenterol Disord; 2003; 3 Suppl 1():S23-9. PubMed ID: 12684586
[TBL] [Abstract][Full Text] [Related]
19. The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy.
Boulton-Jones JR; Pritchard K; Mahmoud AA
Aliment Pharmacol Ther; 2000 Dec; 14(12):1561-5. PubMed ID: 11121903
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis.
Hazlewood GS; Rezaie A; Borman M; Panaccione R; Ghosh S; Seow CH; Kuenzig E; Tomlinson G; Siegel CA; Melmed GY; Kaplan GG
Gastroenterology; 2015 Feb; 148(2):344-54.e5; quiz e14-5. PubMed ID: 25448924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
